Prof. Ruth Arnon Formerly Vice-President of the Weizmann Institute of Science (1988-1997), Professor Arnon is an internationally known immunologist. Along with Prof. Michael Sela, she conceptualized and developed Copaxone®, a drug for the treatment of multiple sclerosis which was approved by the U.S. Food and Drug Administration and is presently marketed worldwide.
Prof. Arnon has made significant contributions in the fields of vaccine development, cancer research and to the study of parasitic diseases. She has served as President of the European Federation of Immunological Societies (EFIS), and as Secretary-General of the International Union of Immunological Societies (IUIS).
Prof. Arnon is the recipient of numerous international and Israeli awards including the prestigious Israel Prize. She is a member of the Israel Academy of Sciences, where she served as President from 2010-2015.